Johnson & Johnson Debt to Equity Ratio 2006-2018 | JNJ

Current and historical debt to equity ratio values for Johnson & Johnson (JNJ) over the last 10 years.
Johnson & Johnson Annual Debt/Equity Ratio
2017 0.58
2016 0.39
2015 0.28
2014 0.27
2013 0.25
2012 0.25
2011 0.34
2010 0.30
2009 0.29
2008 0.28
2007 0.22
2006 0.17
2005 0.07
Johnson & Johnson Quarterly Debt/Equity Ratio
Q2 2018 0.51
Q1 2018 0.51
Q4 2017 0.58
Q3 2017 0.48
Q2 2017 0.48
Q1 2017 0.46
Q4 2016 0.39
Q3 2016 0.37
Q2 2016 0.36
Q1 2016 0.32
Q4 2015 0.28
Q3 2015 0.28
Q2 2015 0.27
Q1 2015 0.28
Q4 2014 0.27
Q3 2014 0.20
Q2 2014 0.22
Q1 2014 0.23
Q4 2013 0.25
Q3 2013 0.22
Q2 2013 0.22
Q1 2013 0.24
Q4 2012 0.25
Q3 2012 0.26
Q2 2012 0.29
Q1 2012 0.32
Q4 2011 0.34
Q3 2011 0.30
Q2 2011 0.30
Q1 2011 0.30
Q4 2010 0.30
Q3 2010 0.21
Q2 2010 0.22
Q1 2010 0.23
Q4 2009 0.29
Q3 2009 0.23
Q2 2009 0.29
Q1 2009 0.32
Q4 2008 0.28
Q3 2008 0.32
Q2 2008 0.30
Q1 2008 0.25
Q4 2007 0.22
Q3 2007 0.18
Q2 2007 0.15
Q1 2007 0.16
Q4 2006 0.17
Q3 2006 0.06
Q2 2006 0.07
Q1 2006 0.07
Q4 2005 0.07
Q3 2005 0.07
Q2 2005 0.08
Q1 2005 0.08
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $347.436B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $242.341B 14.19
Novartis AG (NVS) Switzerland $190.356B 16.33
Merck (MRK) United States $179.189B 15.82
AbbVie (ABBV) United States $145.249B 14.19
Novo Nordisk (NVO) Denmark $118.145B 18.89
Eli Lilly (LLY) United States $110.019B 20.37
Sanofi (SNY) France $103.584B 13.11
AstraZeneca (AZN) United Kingdom $98.732B 10.86
GlaxoSmithKline (GSK) United Kingdom $98.701B 13.18
Bristol-Myers Squibb (BMY) United States $98.007B 17.74